Special Issue "Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies".

Psychiatry stands at a turning point, where molecular insights promise to revolutionize how we diagnose, monitor, and treat neuropsychiatric conditions, including Alzheimer's, Parkinson's, depression, dementia, and schizophrenia (SCZ), among others [...].